Moreover, Kaplan-Meier analysis of NSCLC tissues from TCGA database suggested that patients with higher FAM83A expression had worse overall survival and disease-free survival (P<0.001, P=0.0013; Figure 1C–1D), suggesting that FAM83A may promote progression of NSCLC. The gene discussed is SACK1A; the disease is non-small cell lung carcinoma.